Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation
暂无分享,去创建一个
H. Brückmann | H. Möller | M. Wiesmann | N. Koutsouleris | E. Meisenzahl | T. Frodl | M. Riedel | J. Scheuerecker | G. Schmitt | T. Zetzsche | H. Brückmann | M. Zipse | S. Ufer | I. Spellmann | S. Dehning | J. Linn | T. Frodl | E. M. Meisenzahl | N. Koutsouleris | M. Wiesmann | J. Linn | H. J. Möller | J. Scheuerecker | M. Zipse | S. Ufer | T. Zetzsche | G. Schmitt | M. Riedel | I. Spellmann | S. Dehning | H. Möller | Jennifer Linn | Johanna Scheuerecker
[1] N. Andreasen. The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and Theoretical Foundations , 1989, British Journal of Psychiatry.
[2] J. Callicott,et al. Functional lateralization of the sensorimotor cortex in patients with schizophrenia: effects of treatment with olanzapine , 2004, Biological Psychiatry.
[3] B. Postle,et al. Prefrontal cortical contributions to working memory: evidence from event-related fMRI studies , 2000, Experimental Brain Research.
[4] S. Purdon. Measuring neuropsychological change in schizophrenia with novel antipsychotic medications. , 2000, Journal of psychiatry & neuroscience : JPN.
[5] M. Petrides. Dissociable Roles of Mid-Dorsolateral Prefrontal and Anterior Inferotemporal Cortex in Visual Working Memory , 2000, The Journal of Neuroscience.
[6] A. Malla,et al. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. , 2001, Journal of psychiatry & neuroscience : JPN.
[7] D. Weinberger,et al. Prefrontal function in schizophrenia: confounds and controversies. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[8] H. Möller. Atypical neuroleptics: a new approach in the treatment of negative symptoms , 1999, European Archives of Psychiatry and Clinical Neuroscience.
[9] R. Coppola,et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. , 2000, Cerebral cortex.
[10] R. Coppola,et al. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. , 1999, Cerebral cortex.
[11] Steven Warach,et al. Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI , 1999, Biological Psychiatry.
[12] M. Egan,et al. Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. , 2003, The American journal of psychiatry.
[13] Alexander L. Miller,et al. Does cognitive function improve with quetiapine in comparison to haloperidol? , 2002, Schizophrenia Research.
[14] T. Robbins,et al. The case of frontostriatal dysfunction in schizophrenia. , 1990, Schizophrenia bulletin.
[15] S. Kiebel,et al. An Introduction to Random Field Theory , 2003 .
[16] I. Kiss,et al. Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: An interim analysis , 2002, British Journal of Psychiatry.
[17] J. Kelsoe,et al. Genetics of affective disorders , 2001, European Neuropsychopharmacology.
[18] T. Sharma. Quetiapine – efficacy in different domains , 2001, European Neuropsychopharmacology.
[19] Steven C. R. Williams,et al. Cortical effects of quetiapine in first-episode schizophrenia: A preliminary functional magnetic resonance imaging study , 2004, Biological Psychiatry.
[20] Ravi S. Menon,et al. Imaging function in the working brain with fMRI , 2001, Current Opinion in Neurobiology.
[21] E. Bullmore,et al. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[22] Jonathan D. Cohen,et al. Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia , 2003, Biological Psychiatry.
[23] P. Goldman-Rakic. Working memory dysfunction in schizophrenia. , 1994, The Journal of neuropsychiatry and clinical neurosciences.
[24] Peter Stoeter,et al. Altered effective connectivity during working memory performance in schizophrenia: a study with fMRI and structural equation modeling , 2003, NeuroImage.
[25] J. Schmahmann,et al. Cerebellar cognitive affective syndrome. , 1997, International review of neurobiology.
[26] H. Möller,et al. Cerebral changes and cognitive dysfunctions in medication-free schizophrenia - an fMRI study. , 2008, Journal of psychiatric research.
[27] Gregory G Brown,et al. Spatial working memory among middle-aged and older patients with schizophrenia and volunteers using fMRI , 2004, Schizophrenia Research.
[28] H. Möller,et al. Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms , 2005, European Archives of Psychiatry and Clinical Neuroscience.
[29] Bruce R. Rosen,et al. Activity in Ventrolateral and Mid-Dorsolateral Prefrontal Cortex during Nonspatial Visual Working Memory Processing: Evidence from Functional Magnetic Resonance Imaging , 2000, NeuroImage.
[30] J. Cohen,et al. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. , 2001, Archives of general psychiatry.
[31] Jonathan D. Cohen,et al. Dissociating working memory from task difficulty in human prefrontal cortex , 1997, Neuropsychologia.
[32] S. Potkin,et al. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. , 1992, Archives of general psychiatry.
[33] L. Arvanitis,et al. Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo , 1997, Biological Psychiatry.
[34] C. Fahim,et al. Restoration of frontal activation during a treatment with quetiapine: an fMRI study of blunted affect in schizophrenia , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[35] C. M. Parkes. Psychiatric Problems Following Bereavement by Murder or Manslaughter , 1993, British Journal of Psychiatry.
[36] C. Fahim,et al. Differential Hemodynamic Brain Activity in Schizophrenia Patients With Blunted Affect During Quetiapine Treatment , 2005, Journal of clinical psychopharmacology.
[37] V. Peralta,et al. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study , 2001, Schizophrenia Research.
[38] O. Sabri,et al. Cerebral correlates of selective attention in schizophrenic patients with formal thought disorder: a controlled H2 15O-PET study , 2002, Psychiatry Research: Neuroimaging.
[39] M. Egan,et al. Comparison of Cognitive Performances During a Placebo Period and an Atypical Antipsychotic Treatment Period in Schizophrenia: Critical Examination of Confounds , 2003, Neuropsychopharmacology.
[40] S. Rauch,et al. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance , 2000, Biological Psychiatry.